U.S. Logistics Stock News

Lineage (LINE) is back in focus after reporting fourth quarter and full year 2025 results, which included a swing to a Q4 profit and a sharply smaller annual net loss, catching investors’ attention. See our latest analysis for Lineage. At a share price of US$40.52, Lineage has seen a 5.8% 7 day share price return, a 13.5% 30 day share price return, and a 14.4% year to date share price return. However, its 1 year total shareholder return of a 29.3% decline shows that recent momentum is...

Why Qnity Electronics (Q) Is Back on Investors’ Radar Qnity Electronics (Q) has drawn fresh attention after reporting Q4 2025 results that topped analyst revenue and earnings expectations, rolling out a multi year productivity plan, and approving a US$500 million share repurchase program. See our latest analysis for Qnity Electronics. The strong Q4 surprise, fresh 2026 net sales guidance and new M&A ambitions have coincided with powerful momentum, with a 30 day share price return of 31.8% and...

Ryder System recently reported fourth-quarter 2025 results that exceeded expectations and paired them with an upbeat earnings outlook for 2026, highlighting resilient performance across its logistics and vehicle services operations. This strong update comes shortly after sizable insider share sales by senior executives, drawing attention to how leadership actions align with Ryder’s growth and capital allocation plans. With Ryder’s better-than-expected quarter and optimistic 2026 guidance now...

iRhythm Holdings (IRTC) has drawn fresh attention after recent share price moves, with the stock showing a 4.6% decline over the past day and a 13.4% slide over the past month. See our latest analysis for iRhythm Holdings. The recent 1 day share price return of 4.6% decline adds to a 30 day share price return of 13.4% decline and a year to date share price return of 23.7% decline. At the same time, the 1 year total shareholder return of 22.6% shows a very different long term picture,...

In recent months, Scorpio Tankers reported strong fourth-quarter results, with net income rising to US$128.1 million and daily TCE rates increasing year over year, while shifting its balance sheet from US$3.10 billions in net debt in 2021 to roughly US$334 million in net cash by early 2026. The company complemented this financial improvement with a higher quarterly dividend of US$0.45 per share and continued investment in scrubber-fitted vessels, pointing to a focus on cash returns and...

Preferred Bank (PFBC) has drawn fresh attention after recent trading left the stock around $87.72. Mixed returns over the past week, month and past 3 months are prompting investors to reassess its current valuation. See our latest analysis for Preferred Bank. The recent 1 day share price decline of 3.36% and year to date share price return of negative 8.57% contrast with a 1 year total shareholder return of 3.12%. This suggests shorter term momentum has cooled even as longer term holders have...

Madison Square Garden Entertainment Corp. recently disclosed that a data breach discovered on or about December 16, 2025 exposed personal information via a vulnerability in Oracle’s eBusiness Suite, prompting legal investigations by Edelson Lechtzin LLP on behalf of affected individuals. Beyond potential legal and remediation costs, this incident puts the company’s data security and operational controls under scrutiny at a time when it relies heavily on customer trust for its live...

F&G Annuities & Life, Inc. and Voya Financial, Inc. previously announced that F&G’s annuity solutions would be distributed through Voya’s Wealth Management platform, giving Voya financial professionals access to F&G products, education and support for retirement and income protection planning. This collaboration combines F&G’s product range with Voya’s advisory reach, potentially broadening F&G’s presence in the US retirement market and deepening advisor adoption of its annuity...

Relay Therapeutics, Inc. recently reported full-year 2025 results, with revenue rising to US$15.36 million from US$10.01 million and its net loss narrowing to US$276.48 million from US$337.71 million, while also securing FDA Breakthrough Therapy designation and advancing multiple 2026 data milestones for lead asset zovegalisib. Alongside a narrower basic loss per share of US$1.61 versus US$2.36 a year earlier, the company filed a US$96.18 million common-stock shelf registration tied to an...

Astec Industries, Inc. has now reported its fourth-quarter and full-year 2025 results, with Q4 sales rising to US$400.6 million from US$359.0 million and full-year sales reaching US$1.41 billion, while net income increased to US$38.8 million for 2025 and the Board maintained a quarterly dividend of US$0.13 per share payable in March 2026. Despite Q4 net income easing year on year, the company delivered record quarterly and annual sales, beat analyst earnings and revenue expectations,...

IMAX Corporation recently reported fourth-quarter 2025 revenue of US$125.21 million and full-year 2025 revenue of US$410.21 million, with annual net income rising to US$34.88 million even as quarterly net income softened. The company paired these record box office and revenue results with ongoing global network expansion and deeper local-language and live-event content partnerships, including a new collaboration with Apple TV to screen select 2026 Formula One races in IMAX theaters. We’ll...

Chemed Corporation recently reported fourth-quarter 2025 results showing net income of US$76.75 million and full-year 2025 net income of US$265.24 million, both lower than the prior year, alongside 2026 adjusted earnings guidance of US$23.25–US$24.25 per diluted share. Despite ongoing share repurchases totaling US$2.62 billion since 2011, investors focused on pressure in VITAS and Roto-Rooter margins, including Medicare Cap constraints and water-restoration write-offs. We’ll now examine how...

In February 2026, Guardant Health reported fourth-quarter 2025 revenue of US$281.27 million and a net loss of US$128.49 million, filed a US$510.17 million shelf registration for 4,795,700 common shares tied to employee stock plans, and issued 2026 revenue guidance of US$1.25–1.28 billion. Alongside these filings and results, Guardant’s inclusion as a leading contributor in an institutional growth fund and commentary about volume-driven expansion and acquisition activity highlighted growing...

In February 2026, The Allstate Corporation declared approximately US$29.3 million in cash dividends on its Series H, I and J preferred stock for the January 15 to April 14 period, payable on April 15 to stockholders of record on March 31, alongside board approval of a higher quarterly common dividend of US$1.08 per share. This combination of stronger earnings, improved auto and homeowners loss ratios, and increased common and preferred dividends underlines management’s confidence in the...

Tarsus Pharmaceuticals (TARS) recently reported full year 2025 results, with revenue of US$451.36 million and a net loss of US$66.42 million, and also filed a US$141.73 million shelf registration. See our latest analysis for Tarsus Pharmaceuticals. The latest earnings improvement and governance changes appear to sit behind a strong share price recovery, with a 30 day share price return of 17.01% and a one year total shareholder return of 76.78%. This is despite the year to date share price...

In February 2026, Copart, Inc. reported that its second-quarter revenue slipped to US$1,121.67 million from US$1,163.32 million a year earlier, with net income easing to US$350.73 million and diluted earnings per share from continuing operations at US$0.36 versus US$0.40. An interesting contrast is that while quarterly revenue and profit dipped year over year, Copart’s net income for the first half of the fiscal year edged up slightly to US$754.45 million, with earnings per share essentially...

QuidelOrtho (QDEL) has drawn fresh investor attention after announcing a long-term supply agreement with Lifotronic Technology, giving the diagnostics company access to additional immunoassay analyzers and more than 70 assays across select markets outside the United States. See our latest analysis for QuidelOrtho. That supply agreement arrives at a time when QuidelOrtho’s share price has seen a 7.31% 7 day gain to US$22.74, but its year to date share price return of 20.99% and 1 year total...

Earnings and leadership changes draw focus to Erie Indemnity (ERIE) Erie Indemnity (ERIE) has moved into the spotlight after releasing its full year 2025 results, showing revenue of US$4,067.26 million alongside lower net income and earnings per share compared with the prior year. See our latest analysis for Erie Indemnity. Investors have been weighing the full year 2025 results and the planned CEO transition against recent market performance, with the share price at US$269.44 and a 1 year...

The RealReal, Inc. recently reported past fourth-quarter and 2025 results showing revenue rising to US$194.05 million for the quarter and US$692.85 million for the year, with its annual net loss narrowing to US$41.8 million as the company achieved positive adjusted EBITDA in every quarter. Alongside this profitability progress, The RealReal filed a US$77.88 million shelf registration tied to its ESOP and reopened its reimagined San Francisco flagship, underscoring how AI-enabled efficiency...

Why Terreno Realty is on investors’ radar today Terreno Realty (TRNO) is drawing fresh attention after recent price moves, with the stock last closing at US$66.06 and showing mixed returns over the past month and past 3 months. See our latest analysis for Terreno Realty. Terreno Realty’s recent move to US$66.06 comes alongside a 7.34% 1 month share price return and an 11.93% year to date share price return. Its 5 year total shareholder return of 36.75% points to steadier long term...

Nucor Corporation’s board recently declared a regular quarterly cash dividend of US$0.56 per share, its 212th consecutive payout, and authorized a new US$4.00 billion share repurchase program after completing the prior US$3.69 billion buyback. The company also reshaped its senior leadership team by appointing John L. “Jack” Sullivan as Chief Financial Officer, Treasurer and Executive Vice President, following Steve Laxton’s earlier move to President and Chief Operating Officer. We’ll now...

Dynex Capital, Inc. recently appointed Michael Sartori, formerly Head of Capital Markets and Financial Planning and Analysis, as Chief Financial Officer, succeeding Robert Colligan, who will remain in an advisory role until May 1, 2026, with the company stating the transition is unrelated to financial reporting or control issues. Sartori’s long tenure at Dynex and deep experience in capital markets, derivatives accounting, and financial modeling positions him to influence how the mortgage...

Without a specific news headline driving attention, Belden (BDC) is drawing interest as investors look at its recent share performance, business profile, and current financial footprint in data infrastructure and industrial connectivity. See our latest analysis for Belden. Belden’s share price has pulled back 2.7% over the last day but still sits at US$143.30 after a strong 30 day share price return of 21.95% and a 1 year total shareholder return of 30.46%, which points to momentum that has...

Metropolitan Bank Holding Corp. recently completed a follow-on public offering of 2,100,000 common shares at US$85.00 each, raising about US$178.5 million to bolster capital and fund organic growth, technology investment, and general corporate purposes. The move meaningfully expands the bank’s equity base while supporting its post–Project Phoenix push into technology and AI-driven efficiency, reshaping how it finances future expansion. We’ll now examine how this sizeable equity raise, aimed...